Literature DB >> 19291508

AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences.

Kip Bodi1, Tatiana Prokaeva, Brian Spencer, Maurya Eberhard, Lawreen H Connors, David C Seldin.   

Abstract

AL-Base, a curated database of human immunoglobulin (Ig) light chain (LC) sequences derived from patients with AL amyloidosis and controls, is described, along with a collection of analytical and graphic tools designed to facilitate their analysis. AL-Base is designed to compile and analyse amyloidogenic Ig LC sequences and to compare their predicted protein sequence and structure to non-amyloidogenic LC sequences. Currently, the database contains over 3000 de-identified LC nucleotide and amino acid sequences, of which 433 encode monoclonal proteins that were reported to form fibrillar deposits in AL patients. Each sequence is categorised according to germline gene usage, clinical status and sample source. Currently, tools are available to search for sequences by various criteria, to analyse the biochemical properties of the predicted amino acids at each position and to display the results in a graphical fashion. The likelihood that each sequence has evolved through somatic hypermutation can be predicted using an automated binomial or multinomial distribution model. AL-Base is available to the scientific community for research purposes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291508      PMCID: PMC4123194          DOI: 10.1080/13506120802676781

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  31 in total

Review 1.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.

Authors:  Marie-Paule Lefranc; Christelle Pommié; Manuel Ruiz; Véronique Giudicelli; Elodie Foulquier; Lisa Truong; Valérie Thouvenin-Contet; Gérard Lefranc
Journal:  Dev Comp Immunol       Date:  2003-01       Impact factor: 3.636

2.  Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.

Authors:  Vittorio Perfetti; Simona Casarini; Giovanni Palladini; Maurizio Colli Vignarelli; Catherine Klersy; Marta Diegoli; Edoardo Ascari; Giampaolo Merlini
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

3.  Rationalization of the effects of mutations on peptide and protein aggregation rates.

Authors:  Fabrizio Chiti; Massimo Stefani; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

Review 4.  Experimental investigation of protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Methods       Date:  2004-09       Impact factor: 3.608

5.  Altered dimer interface decreases stability in an amyloidogenic protein.

Authors:  Elizabeth M Baden; Barbara A L Owen; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado; James R Thompson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

6.  The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.

Authors:  M J Stone; E P Frendel
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

7.  The characterization of amino acid sequences in proteins by statistical methods.

Authors:  J M Zimmerman; N Eliezer; R Simha
Journal:  J Theor Biol       Date:  1968-11       Impact factor: 2.691

8.  [Proceedings: A simple statistical method to predict protein conformations].

Authors:  F Beghin; J Dirkx
Journal:  Arch Int Physiol Biochim       Date:  1975-02

9.  Four structural risk factors identify most fibril-forming kappa light chains.

Authors:  F J Stevens
Journal:  Amyloid       Date:  2000-09       Impact factor: 7.141

10.  IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties.

Authors:  Christelle Pommié; Séverine Levadoux; Robert Sabatier; Gérard Lefranc; Marie-Paule Lefranc
Journal:  J Mol Recognit       Date:  2004 Jan-Feb       Impact factor: 2.137

View more
  25 in total

1.  Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.

Authors:  Boris Brumshtein; Shannon R Esswein; Michael R Sawaya; Gregory Rosenberg; Alan T Ly; Meytal Landau; David S Eisenberg
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

2.  Unfolded protein response activation reduces secretion and extracellular aggregation of amyloidogenic immunoglobulin light chain.

Authors:  Christina B Cooley; Lisa M Ryno; Lars Plate; Gareth J Morgan; John D Hulleman; Jeffery W Kelly; R Luke Wiseman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

3.  Formation of amyloid fibers by monomeric light chain variable domains.

Authors:  Boris Brumshtein; Shannon R Esswein; Meytal Landau; Christopher M Ryan; Julian P Whitelegge; Martin L Phillips; Duilio Cascio; Michael R Sawaya; David S Eisenberg
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

4.  Stabilization of amyloidogenic immunoglobulin light chains by small molecules.

Authors:  Gareth J Morgan; Nicholas L Yan; David E Mortenson; Enrico Rennella; Joshua M Blundon; Ryan M Gwin; Chung-Yon Lin; Robyn L Stanfield; Steven J Brown; Hugh Rosen; Timothy P Spicer; Virneliz Fernandez-Vega; Giampaolo Merlini; Lewis E Kay; Ian A Wilson; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

5.  Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome.

Authors:  Sébastien Bender; Vincent Javaugue; Alexis Saintamand; Maria Victoria Ayala; Mehdi Alizadeh; Matthieu Filloux; Virginie Pascal; Nathalie Gachard; David Lavergne; Fabienne Auroy; Michel Cogné; Frank Bridoux; Christophe Sirac; Arnaud Jaccard
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

6.  Structural basis for the stabilization of amyloidogenic immunoglobulin light chains by hydantoins.

Authors:  Nicholas L Yan; Diogo Santos-Martins; Enrico Rennella; Brittany B Sanchez; Jason S Chen; Lewis E Kay; Ian A Wilson; Gareth J Morgan; Stefano Forli; Jeffery W Kelly
Journal:  Bioorg Med Chem Lett       Date:  2020-06-16       Impact factor: 2.823

Review 7.  Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Perry Elliott; Raymond Comenzo; Marc Semigran; Claudio Rapezzi
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

8.  The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain.

Authors:  Elena S Klimtchuk; Olga Gursky; Rupesh S Patel; Kathryn L Laporte; Lawreen H Connors; Martha Skinner; David C Seldin
Journal:  Biochemistry       Date:  2010-10-20       Impact factor: 3.162

9.  Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.

Authors:  Jun Zhao; Baohong Zhang; Jianwei Zhu; Ruth Nussinov; Buyong Ma
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-12       Impact factor: 5.187

10.  siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.

Authors:  X Ma; P Zhou; S W Wong; M Warner; C Chaulagain; R L Comenzo
Journal:  Gene Ther       Date:  2016-06-20       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.